Evaluation of calculating carboplatin dosage in carboplatin–pemetrexed therapy as the first‐line therapy for Chinese patients with advanced lung adenocarcinoma

OBJECTIVE: This study aims to explore the application of actual carboplatin in carboplatin plus pemetrexed regimen as first‐line treatment for advanced lung adenocarcinoma, and to determine the recommended dose of carboplatin for Chinese populations. METHODS: From January 2014 to April 2016, 151 adv...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Thorac Cancer
Päätekijät: Zhu, Yixiang, Xing, Puyuan, Wang, Shouzheng, Ma, Di, Mu, Yuxin, Li, Xue, Xu, Ziyi, Li, Junling
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: John Wiley & Sons Australia, Ltd 2018
Aiheet:
Original Articles
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5832477/
https://ncbi.nlm.nih.gov/pubmed/29377581
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.12594
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia